Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 37 Carcinoma, Non-Small-Cell Lung 29 Prostatic Neoplasms 20 Neoplasm Metastasis 19 Breast Neoplasms 19 Colorectal Neoplasms 17 Squamous Cell Carcinoma of Head and Neck 14 Leukemia, Myeloid, Acute 14 Stomach Neoplasms 13 Ovarian Neoplasms 12 Melanoma 12 Lung Neoplasms 12 Carcinoma, Hepatocellular 12 Recurrence 11 Hematologic Neoplasms 10 Endometrial Neoplasms 10 Rectal Neoplasms 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Pancreatic Neoplasms 9 Lymphoma 9 Head and Neck Neoplasms 9 Myasthenia Gravis 8 Leukemia 8 Urinary Bladder Neoplasms 7 Neoplasms by Site 7 Neoplasms by Histologic Type 7 Lymphoma, Large B-Cell, Diffuse 7 Glioblastoma 7 Fatigue 6 Colonic Neoplasms 6

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Malignancy of Thyroid Nodules × 1 year × Clear all

NCT03498183 2025-06-06

MIBI-THYR

Nantes University Hospital

Phase 2/3 Completed

Malignancy of Thyroid Nodules

Data powered by HemOnc (CC BY 4.0) Colophon ⚡